AMY YENUMULAPALLY: Open Payments
NPI 1558013482 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 41 payments from 13 companies in 2025. Trend: 2023 $36 · 2024 $750 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $259 |
| Novo Nordisk Inc | 8 | $244 |
| Lilly USA, LLC | 9 | $239 |
| Amgen Inc. | 5 | $180 |
| Ferring Pharmaceuticals Inc. | 2 | $70 |
| Dexcom, Inc. | 3 | $63 |
| PFIZER INC. | 2 | $34 |
| Ethicon Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| ABBVIE INC. | 1 | $21 |
Products named: Auvelity, REPATHA, ZEPBOUND, Ozempic, REBYOTA, Rybelsus, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
